Advertisement
U.S. markets open in 2 hours 40 minutes
  • S&P Futures

    5,068.00
    -13.00 (-0.26%)
     
  • Dow Futures

    38,866.00
    -127.00 (-0.33%)
     
  • Nasdaq Futures

    17,880.25
    -35.00 (-0.20%)
     
  • Russell 2000 Futures

    2,047.60
    +4.20 (+0.21%)
     
  • Crude Oil

    78.20
    -0.34 (-0.43%)
     
  • Gold

    2,038.40
    -4.30 (-0.21%)
     
  • Silver

    22.55
    -0.09 (-0.38%)
     
  • EUR/USD

    1.0835
    -0.0007 (-0.07%)
     
  • 10-Yr Bond

    4.2740
    0.0000 (0.00%)
     
  • Vix

    14.01
    +0.17 (+1.23%)
     
  • GBP/USD

    1.2653
    -0.0007 (-0.06%)
     
  • USD/JPY

    150.0610
    -0.5720 (-0.38%)
     
  • Bitcoin USD

    62,923.73
    +3,810.37 (+6.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,643.64
    +18.66 (+0.24%)
     
  • Nikkei 225

    39,166.19
    -41.84 (-0.11%)
     

Biogen to pay $22 million to resolve U.S. drug charity kickback probe

BOSTON, Dec 17 (Reuters) - Biogen Inc has agreed to pay $22 million to resolve U.S. allegations that it illegally used two charities that help cover Medicare patients' out-of-pocket drug costs as a means to pay them kickbacks to use its multiple sclerosis drugs.

The deal, announced by the U.S. Justice Department on Thursday, was the latest to result from an industry-wide probe of drugmakers' financial support of patient assistance charities that has resulted in more than $1 billion in settlements. (Reporting by Nate Raymond in Boston)

Advertisement